spacer
spacer

PDBsum entry 4jjs

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Transferase/transferase inhibitor PDB id
4jjs

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
559 a.a.
Ligands
1M9
Metals
_MG ×2
Waters ×263
PDB id:
4jjs
Name: Transferase/transferase inhibitor
Title: Crystal structure of hcv ns5b polymerase in complex with compound 2
Structure: Genome polyprotein. Chain: a, b. Fragment: RNA-directed RNA polymerase, unp residues 2420-2989. Synonym: core protein p21, capsid protein c, p21, core protein p19, envelope glycoprotein e1, gp32, gp35, envelope glycoprotein e2, ns1, gp68, gp70, p7, protease ns2-3, p23, serine protease ns3, hepacivirin, ns3p, p70, non-structural protein 4a, ns4a, p8, non- structural protein 4b, ns4b, p27, non-structural protein 5a, ns5a, p56, RNA-directed RNA polymerase, ns5b, p68.
Source: Hepatitis c virus. Hcv. Organism_taxid: 420174. Strain: ibj4. Gene: ns5b. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.20Å     R-factor:   0.236     R-free:   0.272
Authors: R.Coulombe
Key ref: P.L.Beaulieu et al. (2013). Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotype. Bioorg Med Chem Lett, 23, 4132-4140. PubMed id: 23768906 DOI: 10.1016/j.bmcl.2013.05.037
Date:
08-Mar-13     Release date:   12-Jun-13    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
O92972  (POLG_HCVJ4) -  Genome polyprotein from Hepatitis C virus genotype 1b (strain HC-J4)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
3010 a.a.
559 a.a.
Key:    PfamA domain  Secondary structure

 Enzyme reactions 
   Enzyme class 1: E.C.2.7.7.48  - RNA-directed Rna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
RNA(n)
+ ribonucleoside 5'-triphosphate
= RNA(n+1)
+ diphosphate
   Enzyme class 2: E.C.3.4.21.98  - hepacivirin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
   Enzyme class 3: E.C.3.4.22.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 4: E.C.3.6.1.15  - nucleoside-triphosphate phosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
ribonucleoside 5'-triphosphate
+ H2O
= ribonucleoside 5'-diphosphate
+ phosphate
+ H(+)
   Enzyme class 5: E.C.3.6.4.13  - Rna helicase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + H2O = ADP + phosphate + H+
ATP
+ H2O
= ADP
+ phosphate
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/j.bmcl.2013.05.037 Bioorg Med Chem Lett 23:4132-4140 (2013)
PubMed id: 23768906  
 
 
Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotype.
P.L.Beaulieu, R.Coulombe, J.Duan, G.Fazal, C.Godbout, O.Hucke, A.Jakalian, M.A.Joly, O.Lepage, M.Llinàs-Brunet, J.Naud, M.Poirier, N.Rioux, B.Thavonekham, G.Kukolj, T.A.Stammers.
 
  ABSTRACT  
 
We describe the structure-based design of a novel lead chemotype that binds to thumb pocket 2 of HCV NS5B polymerase and inhibits cell-based gt1 subgenomic reporter replicons at sub-micromolar concentrations (EC50<200nM). This new class of potent thumb pocket 2 inhibitors features a 1H-quinazolin-4-one scaffold derived from hybridization of a previously reported, low affinity thiazolone chemotype with our recently described anthranilic acid series. Guided by X-ray structural information, a key NS5B-ligand interaction involving the carboxylate group of anthranilic acid based inhibitors was replaced by a neutral two-point hydrogen bonding interaction between the quinazolinone scaffold and the protein backbone. The in vitro ADME and in vivo rat PK profile of representative analogs are also presented and provide areas for future optimization of this new class of HCV polymerase inhibitors.
 

 

spacer

spacer